• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Pyxis Oncology, Inc. - Common Stock (NQ:PYXS)

    3.465 +0.225 (+6.94%)
    Streaming Delayed Price Updated: 11:16 AM EDT, Sep 1, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 139,216
    Open 3.240
    Bid (Size) 3.450 (200)
    Ask (Size) 3.480 (100)
    Prev. Close 3.240
    Today's Range 3.180 - 3.470
    52wk Range 1.030 - 5.550
    Shares Outstanding 38,245,287
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Pyxis Oncology to Participate in Upcoming Investor Conferences
    From Pyxis Oncology
    Via GlobeNewswire
    News headline image
    Pyxis Oncology Reports Second Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones
    From Pyxis Oncology
    Via GlobeNewswire

    Performance

    YTD
    +201.3%
    +201.3%
    1 Month
    +14.0%
    +14.0%
    3 Month
    +93.6%
    +93.6%
    6 Month
    +135.7%
    +135.7%
    1 Year
    +160.5%
    +160.5%

    More News

    Read More
    What's going on in today's session ↗
    Via Chartmill
    Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
    Via Chartmill
    Top stock movements in today's session. ↗
    Via Chartmill
    News headline image
    Pyxis Oncology Announces Up to $114 Million Private Placement Financing to Advance MICVO Through Key Clinical Milestones
    From Pyxis Oncology
    Via GlobeNewswire
    News headline image
    Pyxis Oncology Reports First Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones
    From Pyxis Oncology
    Via GlobeNewswire
    News headline image
    Pyxis Oncology to Participate in Upcoming Investor Conferences
    From Pyxis Oncology
    Via GlobeNewswire
    News headline image
    Pyxis Oncology Appoints Nelson Azoulay as Chief Business Officer
    From Pyxis Oncology
    Via GlobeNewswire
    News headline image
    Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
    From Pyxis Oncology
    Via GlobeNewswire
    News headline image
    Pyxis Oncology Announces Interim CEO Appointment and Leadership Transition to Support Strategic Focus and Program Continuity
    From Pyxis Oncology
    Via GlobeNewswire
    News headline image
    The $225B Precision Sprint: How Big Pharma is Beating the $170B Patent Cliff
    From Equity Insider
    Via GlobeNewswire
    Curious about the stocks that are showing activity after the closing bell on Friday? ↗
    Via Chartmill
    News headline image
    Unusual volume stocks in Tuesday's session ↗
    Via Chartmill
    News headline image
    Top movers in Thursday's session ↗
    Via Chartmill
    News headline image
    Keep an eye on the top gainers and losers in Thursday's session. ↗
    Via Chartmill
    News headline image
    There are notable gap-ups and gap-downs in today's session. ↗
    Via Chartmill
    News headline image
    Discover the top movers in Thursday's pre-market session. ↗
    Via Chartmill
    News headline image
    Pyxis Oncology Announces Positive Preliminary Phase 1 Data for Micvotabart Pelidotin (MICVO) in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
    From Pyxis Oncology
    Via GlobeNewswire
    News headline image
    Pyxis Oncology to Participate in Upcoming Investor Conferences
    From Pyxis Oncology
    Via GlobeNewswire
    News headline image
    Pyxis Oncology Provides Business Update and Reports Third Quarter 2025 Financial Results
    From Pyxis Oncology
    Via GlobeNewswire
    News headline image
    Pyxis Oncology to Present Translational Data and Key Biology Findings Elucidating the Mechanism of Action of MICVO at Upcoming Medical Meetings
    From Pyxis Oncology
    Via GlobeNewswire
    News headline image
    Pyxis Oncology Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets
    From Pyxis Oncology
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Monday's After-Market Session ↗
    Via Benzinga
    News headline image
    Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Pyxis Oncology
    Via GlobeNewswire

    Frequently Asked Questions

    Is Pyxis Oncology, Inc. - Common Stock publicly traded?
    Yes, Pyxis Oncology, Inc. - Common Stock is publicly traded.
    What exchange does Pyxis Oncology, Inc. - Common Stock trade on?
    Pyxis Oncology, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Pyxis Oncology, Inc. - Common Stock?
    The ticker symbol for Pyxis Oncology, Inc. - Common Stock is PYXS on the Nasdaq Stock Market
    What is the current price of Pyxis Oncology, Inc. - Common Stock?
    The current price of Pyxis Oncology, Inc. - Common Stock is 3.465
    When was Pyxis Oncology, Inc. - Common Stock last traded?
    The last trade of Pyxis Oncology, Inc. - Common Stock was at 09/01/26 11:16 AM ET
    What is the market capitalization of Pyxis Oncology, Inc. - Common Stock?
    The market capitalization of Pyxis Oncology, Inc. - Common Stock is 132.52M
    How many shares of Pyxis Oncology, Inc. - Common Stock are outstanding?
    Pyxis Oncology, Inc. - Common Stock has 133M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.